
Latest Health News
Global Child Mortality Rises Amid Health Funding Cuts
The 2025 Goalkeepers Report from the Bill & Melinda Gates Foundation reveals a reversal in decades-long progress as child deaths under five rise to an estimated 4.8 million in 2025. Health funding has dropped by 27%, threatening millions more lives, especially in Africa. However, new vaccines and advanced malaria tools offer hope for saving millions by 2045.
2025 Nobel Prize in Physiology or Medicine Awarded for Immunology Breakthroughs
American researchers Mary Brunkow and Fred Ramsdell, along with Japan’s Shimon Sakaguchi, won the Nobel for discovering how the immune system distinguishes healthy cells from harmful ones. Their work on regulatory T cells and the FOX P3 gene opens pathways for treating autoimmune diseases and cancer.
WHO and World Bank Release 2025 Global Monitoring Report on Universal Health Coverage
The report analyzes health service coverage trends up to 2023 and financial hardship from health spending up to 2022. It highlights challenges countries face in expanding coverage while reducing financial risks, emphasizing the need for policy changes to achieve Sustainable Development Target 3.8.
Wave Life Sciences to Announce Interim Data from Phase 1 Obesity Drug Trial
Wave Life Sciences will release interim results for WVE-007, an RNA-based therapeutic targeting metabolic pathways for obesity treatment. The ongoing INLIGHT trial assesses safety and metabolic outcomes in adults with overweight or obesity in multiple US sites.
Genetically Engineered Pig Liver Successfully Implanted in Human Trial
Researchers implanted a genetically modified pig liver that functioned for an extended period, supporting essential liver processes before removal due to complications. This marks a significant step in xenotransplantation, potentially reshaping organ replacement therapy
.
Gates Foundation and Qatar Commit $500 Million to Global Health and Education
The partnership focuses on strengthening vaccine initiatives like Gavi and tackling diseases such as AIDS, tuberculosis, and malaria. This funding aims to counteract recent health financing declines and support global health resilience.
ProstACT Global Phase 3 Trial Advances Prostate Cancer Treatment
Telix Pharmaceuticals dosed the first patient in the international trial combining PSMA-targeted radio antibody-drug conjugate therapy with standard care. The study expands to multiple countries, aiming to improve outcomes in advanced prostate cancer patients.